Ambu Toekomstige groei

Future criteriumcontroles 4/6

Ambu zal naar verwachting groeien in winst en omzet met respectievelijk 28.1% en 11.4% per jaar. De winst per aandeel zal naar verwachting groeien met 32.6% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 15.2% zijn.

Belangrijke informatie

28.1%

Groei van de winst

32.6%

Groei van de winst per aandeel

Medical Equipment winstgroei	18.6%
Inkomstengroei	11.4%
Toekomstig rendement op eigen vermogen	15.2%
Dekking van analisten	Good
Laatst bijgewerkt	15 Nov 2024

Recente toekomstige groei-updates

Earnings Miss: Ambu A/S Missed EPS By 54% And Analysts Are Revising Their Forecasts

Nov 07

Ambu A/S Just Beat EPS By 15%: Here's What Analysts Think Will Happen Next

Sep 02

Results: Ambu A/S Exceeded Expectations And The Consensus Has Updated Its Estimates

Feb 01

Recent updates

Ambu's (CPH:AMBU B) Strong Earnings Are Of Good Quality

Nov 13

Earnings Miss: Ambu A/S Missed EPS By 54% And Analysts Are Revising Their Forecasts

Nov 07

Results: Ambu A/S Exceeded Expectations And The Consensus Has Updated Its Estimates

Feb 01

A Piece Of The Puzzle Missing From Ambu A/S' (CPH:AMBU B) Share Price

Jan 02

Is Ambu A/S (CPH:AMBU B) Trading At A 42% Discount?

Oct 31

Ambu (CPH:AMBU B) Will Want To Turn Around Its Return Trends

Sep 22

Does Ambu (CPH:AMBU B) Have A Healthy Balance Sheet?

Aug 19

Does This Valuation Of Ambu A/S (CPH:AMBU B) Imply Investors Are Overpaying?

Jul 12

Returns On Capital At Ambu (CPH:AMBU B) Paint A Concerning Picture

Jun 22

Ambu (CPH:AMBU B) Has A Somewhat Strained Balance Sheet

May 07

Returns On Capital At Ambu (CPH:AMBU B) Paint A Concerning Picture

Mar 24

We Think Ambu (CPH:AMBU B) Is Taking Some Risk With Its Debt

Jan 20

Ambu (CPH:AMBU B) Will Be Hoping To Turn Its Returns On Capital Around

Dec 08

Is Ambu A/S (CPH:AMBU B) Trading At A 30% Discount?

Sep 23

Ambu (CPH:AMBU B) Will Want To Turn Around Its Return Trends

Sep 08

We Think Ambu (CPH:AMBU B) Is Taking Some Risk With Its Debt

Aug 21

Ambu (CPH:AMBU B) Could Be Struggling To Allocate Capital

Jun 06

These 4 Measures Indicate That Ambu (CPH:AMBU B) Is Using Debt Extensively

May 19

Does Ambu (CPH:AMBU B) Have A Healthy Balance Sheet?

Jan 23

Are Investors Undervaluing Ambu A/S (CPH:AMBU B) By 27%?

Dec 12

Winst- en omzetgroeiprognoses

CPSE:AMBU B - Toekomstschattingen van analisten en financiële gegevens uit het verleden (DKK Millions )
Datum	Inkomsten	Inkomsten	Vrije kasstroom	Geldmiddelen uit operationele activiteiten	Gem. Aantal analisten
9/30/2027	7,615	1,058	883	1,333	4
9/30/2026	6,771	816	643	1,046	6
9/30/2025	6,039	638	466	839	6
9/30/2024	5,391	235	524	813	N/A
6/30/2024	5,263	450	614	893	N/A
3/31/2024	5,075	367	608	902	N/A
12/31/2023	4,897	238	501	805	N/A
9/30/2023	4,775	168	192	518	N/A
6/30/2023	4,679	-42	-168	217	N/A
3/31/2023	4,612	-65	-318	119	N/A
12/31/2022	4,545	95	-475	25	N/A
9/30/2022	4,444	93	-463	95	N/A
6/30/2022	4,307	222	-401	185	N/A
3/31/2022	4,152	256	-521	107	N/A
12/31/2021	4,031	176	-419	194	N/A
9/30/2021	4,013	247	-256	328	N/A
6/30/2021	3,858	251	-187	347	N/A
3/31/2021	3,832	281	111	593	N/A
12/31/2020	3,820	290	56	511	N/A
9/30/2020	3,567	241	-135	295	N/A
6/30/2020	3,302	146	-24	366	N/A
3/31/2020	3,128	270	-62	277	N/A
12/31/2019	2,924	296	37	330	N/A
9/30/2019	2,820	317	272	533	N/A
6/30/2019	2,943	515	361	597	N/A
3/31/2019	2,843	411	316	553	N/A
12/31/2018	2,709	372	327	560	N/A
9/30/2018	2,606	337	318	554	N/A
6/30/2018	2,506	318	N/A	498	N/A
3/31/2018	2,434	288	N/A	456	N/A
12/31/2017	2,396	281	N/A	476	N/A
9/30/2017	2,355	301	N/A	462	N/A
6/30/2017	2,299	306	N/A	403	N/A
3/31/2017	2,215	299	N/A	460	N/A
12/31/2016	2,134	267	N/A	420	N/A
9/30/2016	2,084	250	N/A	369	N/A
6/30/2016	2,047	224	N/A	408	N/A
3/31/2016	2,012	169	N/A	269	N/A
12/31/2015	1,963	175	N/A	246	N/A
9/30/2015	1,889	152	N/A	208	N/A
6/30/2015	1,795	171	N/A	141	N/A
3/31/2015	1,710	184	N/A	137	N/A
12/31/2014	1,630	156	N/A	147	N/A
9/30/2014	1,584	151	N/A	183	N/A
6/30/2014	1,543	94	N/A	167	N/A
3/31/2014	1,524	67	N/A	141	N/A
12/31/2013	1,456	40	N/A	148	N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De verwachte winstgroei AMBU B ( 28.1% per jaar) ligt boven de spaarquote ( 1.2% ).

Winst versus markt: De winst van AMBU B ( 28.1% per jaar) zal naar verwachting sneller groeien dan de Danish markt ( 11.6% per jaar).

Hoge groeiwinsten: De winst van AMBU B zal naar verwachting de komende 3 jaar aanzienlijk groeien.

Omzet versus markt: De omzet van AMBU B ( 11.4% per jaar) zal naar verwachting sneller groeien dan de markt Danish ( 10% per jaar).

Hoge groei-inkomsten: De omzet van AMBU B ( 11.4% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Het rendement op eigen vermogen AMBU B zal naar verwachting over 3 jaar laag zijn ( 15.2 %).

Ambu Toekomstige groei

Future criteriumcontroles 4/6

Belangrijke informatie

Recente toekomstige groei-updates

Earnings Miss: Ambu A/S Missed EPS By 54% And Analysts Are Revising Their Forecasts

Ambu A/S Just Beat EPS By 15%: Here's What Analysts Think Will Happen Next

Price target increased by 8.1% to kr.123

Consensus EPS estimates increase by 14%

Results: Ambu A/S Exceeded Expectations And The Consensus Has Updated Its Estimates

Ambu A/S Maintains Earnings Guidance for the Full-Year 2023/24

Recent updates

Ambu's (CPH:AMBU B) Strong Earnings Are Of Good Quality

Ambu A/S Proposes Dividend

Earnings Miss: Ambu A/S Missed EPS By 54% And Analysts Are Revising Their Forecasts

Full year 2024 earnings: EPS misses analyst expectations

Ambu A/S, Annual General Meeting, Dec 03, 2025

Ambu A/S to Report Q1, 2025 Results on Jan 30, 2025

Ambu A/S Just Beat EPS By 15%: Here's What Analysts Think Will Happen Next

Third quarter 2024 earnings: EPS exceeds analyst expectations

Price target increased by 8.1% to kr.123

Here's What's Concerning About Ambu's (CPH:AMBU B) Returns On Capital

Consensus EPS estimates increase by 14%

Second quarter 2024 earnings: EPS misses analyst expectations

Ambu A/S' (CPH:AMBU B) Subdued P/S Might Signal An Opportunity

Returns On Capital Signal Tricky Times Ahead For Ambu (CPH:AMBU B)

Results: Ambu A/S Exceeded Expectations And The Consensus Has Updated Its Estimates

First quarter 2024 earnings released

Ambu A/S Maintains Earnings Guidance for the Full-Year 2023/24

Price target increased by 10% to kr.101

Price target increased by 7.2% to kr.91.83

A Piece Of The Puzzle Missing From Ambu A/S' (CPH:AMBU B) Share Price

Ambu A/S Elects Shacey Petrovic as Vice Chair of Board of Directors

Ambu A/S Announces Henrik Ehlers Wulff Not to Run for Re-Election for Board of Directors

Ambu A/S Provides Earnings Guidance for the Full-Year 2023/24

Price target decreased by 9.0% to kr.87.00

Is Ambu A/S (CPH:AMBU B) Trading At A 42% Discount?

Ambu A/S Appoints Henrik Skak Bender as Member of the Executive Management, Effective 1 January 2024

Ambu A/S Announces Chief Financial Officer Changes

Ambu A/S to Report Q2, 2024 Results on May 14, 2024

Ambu (CPH:AMBU B) Will Want To Turn Around Its Return Trends

Ambu A/S Narrows Earnings Guidance for the Full-Year 2022/23

Third quarter 2023 earnings released

Does Ambu (CPH:AMBU B) Have A Healthy Balance Sheet?

Ambu A/S Raises Earnings Guidance for the Full-Year 2022/2023

Does This Valuation Of Ambu A/S (CPH:AMBU B) Imply Investors Are Overpaying?

Ambu A/S Raises Earnings Guidance for the Full-Year 2022/2023

New minor risk - Share price stability

Returns On Capital At Ambu (CPH:AMBU B) Paint A Concerning Picture

Ambu (CPH:AMBU B) Has A Somewhat Strained Balance Sheet

Second quarter 2023 earnings: Revenues in line with analyst expectations

Price target decreased by 8.7% to kr.95.50

Returns On Capital At Ambu (CPH:AMBU B) Paint A Concerning Picture

Consensus EPS estimates fall by 15%

Consensus EPS estimates increase by 14%

Price target increased by 16% to kr.96.80

First quarter 2023 earnings released: EPS: kr.0.09 (vs kr.0.08 in 1Q 2022)

Ambu A/S Provides Earnings Guidance for the Financial Year of 2022-2023

We Think Ambu (CPH:AMBU B) Is Taking Some Risk With Its Debt

Ambu (CPH:AMBU B) Will Be Hoping To Turn Its Returns On Capital Around

High number of new directors

Ambu A/S Provides Earnings Guidance for the Financial Year of 2022-2023

Full year 2022 earnings: Revenues in line with analyst expectations

Consensus forecasts updated

Ambu A/S to Report Q3, 2023 Results on Aug 31, 2023

Is Ambu A/S (CPH:AMBU B) Trading At A 30% Discount?

Ambu A/S(CPSE:AMBU B) dropped from FTSE All-World Index (USD)

Ambu (CPH:AMBU B) Will Want To Turn Around Its Return Trends

Now 20% undervalued after recent price drop

Price target decreased to kr.76.50

Third quarter 2022 earnings: Revenues in line with analyst expectations

Ambu A/S Reaffirms Earnings Guidance for the Full-Year 2021/2022

We Think Ambu (CPH:AMBU B) Is Taking Some Risk With Its Debt

Consensus forecasts updated

Ambu A/S Revises Earnings Guidance for the Full-Year 2021/2022

Ambu Announces FDA Clearance of Fifth-Generation Single-Use Bronchoscope

Investor sentiment deteriorated over the past week

Ambu (CPH:AMBU B) Could Be Struggling To Allocate Capital

Price target decreased to kr.94.25

Ambu A/S Reaffirms Earnings Guidance for the Fiscal Year 2021/22

These 4 Measures Indicate That Ambu (CPH:AMBU B) Is Using Debt Extensively